These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 17007742

  • 1. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
    Hu X, Feng Y, Shen Y, Zhao XF, Yu JH, Yang YS, Leng Y.
    Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
    [Abstract] [Full Text] [Related]

  • 2. Effect of GCP-02, a PPARalpha/gamma dual activator, on glucose and lipid metabolism in insulin-resistant mice.
    Wang ZJ, Liu Q, Li PP, Zou CH, Shen ZF.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):277-83. PubMed ID: 18048028
    [Abstract] [Full Text] [Related]

  • 3. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
    Carmona MC, Louche K, Nibbelink M, Prunet B, Bross A, Desbazeille M, Dacquet C, Renard P, Casteilla L, Pénicaud L.
    Int J Obes (Lond); 2005 Jul 02; 29(7):864-71. PubMed ID: 15917863
    [Abstract] [Full Text] [Related]

  • 4. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
    Chakrabarti R, Misra P, Vikramadithyan RK, Premkumar M, Hiriyan J, Datla SR, Damarla RK, Suresh J, Rajagopalan R.
    Eur J Pharmacol; 2004 May 03; 491(2-3):195-206. PubMed ID: 15140637
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes.
    Han KL, Choi JS, Lee JY, Song J, Joe MK, Jung MH, Hwang JK.
    Diabetes; 2008 Mar 03; 57(3):737-45. PubMed ID: 18065517
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.
    Minoura H, Takeshita S, Ita M, Hirosumi J, Mabuchi M, Kawamura I, Nakajima S, Nakayama O, Kayakiri H, Oku T, Ohkubo-Suzuki A, Fukagawa M, Kojo H, Hanioka K, Yamasaki N, Imoto T, Kobayashi Y, Mutoh S.
    Eur J Pharmacol; 2004 Jun 28; 494(2-3):273-81. PubMed ID: 15212984
    [Abstract] [Full Text] [Related]

  • 7. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H, Takeshita S, Kimura C, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Mutoh S.
    Diabetes Obes Metab; 2007 May 28; 9(3):369-78. PubMed ID: 17391165
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
    Ide T, Tsunoda M, Mochizuki T, Murakami K.
    Med Sci Monit; 2004 Oct 28; 10(10):BR388-95. PubMed ID: 15448592
    [Abstract] [Full Text] [Related]

  • 9. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
    Xu J, Wang Y, Xu DS, Ruan KF, Feng Y, Wang S.
    Int J Biol Macromol; 2011 Nov 01; 49(4):657-62. PubMed ID: 21756932
    [Abstract] [Full Text] [Related]

  • 10. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK, Chae YN, Son MH, Kim SH, Kim JK, Moon HS, Park CS, Bae MH, Kim E, Han T, Choi HH, Shin YA, Ahn BN, Lee CH, Lim JI, Shin CY.
    Eur J Pharmacol; 2008 Oct 24; 595(1-3):119-25. PubMed ID: 18727927
    [Abstract] [Full Text] [Related]

  • 11. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY, Shen ZF, Chen YT, Sun SJ, Liu Q, Xie MZ.
    Acta Pharmacol Sin; 2005 May 24; 26(5):575-80. PubMed ID: 15842776
    [Abstract] [Full Text] [Related]

  • 12. Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake.
    Hu X, Feng Y, Liu X, Zhao XF, Yu JH, Yang YS, Sydow-Bäckman M, Hörling J, Zierath JR, Leng Y.
    Diabetologia; 2007 May 24; 50(5):1048-57. PubMed ID: 17333104
    [Abstract] [Full Text] [Related]

  • 13. Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.
    Devasthale PV, Chen S, Jeon Y, Qu F, Shao C, Wang W, Zhang H, Cap M, Farrelly D, Golla R, Grover G, Harrity T, Ma Z, Moore L, Ren J, Seethala R, Cheng L, Sleph P, Sun W, Tieman A, Wetterau JR, Doweyko A, Chandrasena G, Chang SY, Humphreys WG, Sasseville VG, Biller SA, Ryono DE, Selan F, Hariharan N, Cheng PT.
    J Med Chem; 2005 Mar 24; 48(6):2248-50. PubMed ID: 15771468
    [Abstract] [Full Text] [Related]

  • 14. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
    Xu C, Wang LL, Liu HY, Zhou XB, Cao YL, Li S.
    Acta Pharmacol Sin; 2006 Feb 24; 27(2):223-8. PubMed ID: 16412273
    [Abstract] [Full Text] [Related]

  • 15. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H, Takeshita S, Yamamoto T, Mabuchi M, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Ita M, Mutoh S.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):182-90. PubMed ID: 16039648
    [Abstract] [Full Text] [Related]

  • 16. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Harrity T, Farrelly D, Tieman A, Chu C, Kunselman L, Gu L, Ponticiello R, Cap M, Qu F, Shao C, Wang W, Zhang H, Fenderson W, Chen S, Devasthale P, Jeon Y, Seethala R, Yang WP, Ren J, Zhou M, Ryono D, Biller S, Mookhtiar KA, Wetterau J, Gregg R, Cheng PT, Hariharan N.
    Diabetes; 2006 Jan 05; 55(1):240-8. PubMed ID: 16380499
    [Abstract] [Full Text] [Related]

  • 17. A novel peroxisome proliferator--activated receptor alpha/gamma dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys.
    Ding SY, Tigno XT, Braileanu GT, Ito K, Hansen BC.
    Metabolism; 2007 Oct 05; 56(10):1334-9. PubMed ID: 17884441
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA, Demichele S, Huang YS, Mika A, Lubbers N, Berthiaume N, Polakowski J, Zinker B.
    Metabolism; 2006 Oct 05; 55(10):1365-74. PubMed ID: 16979408
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor-alpha,gamma-agonist improves insulin sensitivity and prevents loss of left ventricular function in obese dyslipidemic mice.
    Verreth W, Ganame J, Mertens A, Bernar H, Herregods MC, Holvoet P.
    Arterioscler Thromb Vasc Biol; 2006 Apr 05; 26(4):922-8. PubMed ID: 16456093
    [Abstract] [Full Text] [Related]

  • 20. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y, Li Y, Wang Y, Wen Y, Sun C.
    Metabolism; 2009 Dec 05; 58(12):1694-702. PubMed ID: 19767038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.